Compared with the reported other two targets of OXPHOS, mitochondrial ribosome21 and POLRMT16, 19, LRPPRC presents unique advantages: universal high expression in multiple cancers, positive correlation with poor prognosis, and the potential broad applicability to tumor treatment (Figure S12). This evidence concerns the gene LRPPRC and cancer.